Open AccessOptimization of90Y-antiCD20 preparation for radioimmunotherapy
Author(s) -
Nazila Gholipour,
Ariandokht Vakili,
Edalat Radfar,
Amir Reza Jalilian,
Ali Bahrami-Samani,
Simindokht ShirvaniArani,
Mohammad GhannadiMaragheh
Publication year - 2013
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.113350
Subject(s) - radioimmunotherapy , biodistribution , chemistry , conjugate , rituximab , context (archaeology) , monoclonal antibody , antibody , radiochemistry , medicine , immunology , biochemistry , in vitro , biology , mathematical analysis , paleontology , mathematics
The advent of monoclonal antibodies such as Rituximab, in recent years, has brought about decisive progress in the treatment of aggressive and indolent non-Hodgkin's lymphoma.